8-K current report · filed Feb 25, 2026

HCA Healthcare (HCA) 8-K Current Report: February 25, 2026

Item 5.02HCA overview

Short answer

HCA Healthcare (HCA) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). CEO Hazen's 2026 bonus target set at 175% of base salary; CFO Marks and COO Foster at 125%; other EVPs at 100%.

HCA Healthcare 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • CEO Hazen's 2026 bonus target set at 175% of base salary; CFO Marks and COO Foster at 125%; other EVPs at 100%
  • Awards weighted 80% EBITDA / 20% quality metrics; payout range 25%–200% of target for EBITDA, 0%–200% for quality
  • Quality payout zeroed out entirely if actual EBITDA falls below 90% of target: strong earnings-first gating mechanism
  • All awards paid in cash; subject to clawback if financials restated or participant materially disrupts business operations
  • Director Robert J. Dennis retiring from board effective April 23, 2026 annual meeting; not standing for re-election

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other HCA Healthcare 8-K filings

Get the next HCA 8-K as it lands

Follow HCA for push alerts, or ask the research agent what this filing means.